Webdisclosure.com

Search

EDISON INVESTMENT RESEARCH LIMITED (LON:KEFI) Edison Investment Research Limited: Induction Healthcare Group (INHC) initiation – Evolving technology in healthcare

Directive transparence : information réglementée

05/07/2022 08:00

Edison Investment Research Limited
Edison Investment Research Limited: Induction Healthcare Group (INHC) initiation – Evolving technology in healthcare

05-Jul-2022 / 07:00 GMT/BST


 

London, UK, 5 July 2022

 

Induction Healthcare Group (INHC) initiation – Evolving technology in healthcare

Induction Healthcare is a growing UK-based healthcare software company, aiming to provide patients with more flexible care options beyond the traditional face-to-face consultation model. Early in FY22, management acquired Attend Anywhere, which was transformative for the business, leading to revenue growth of 8x and a move to adjusted EBITDA break-even. Our forecasts indicate further growth in revenue and profitability, which should be supported by its robust cash position.

 

At 2.1x FY23e EV/sales, Induction trades at a 38% discount to its peers. Were the shares to trade in line with the peers, the implied share price would be 73.4p, suggesting an upside of 51%.  


Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached – across institutions, family offices, wealth managers and retail investors – Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Max Hayes +44 (0)20 3077 5700 tech@edisongroup.com

Kenneth Mestemacher +44 (0)20 3077 5700 tech@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn        www.linkedin.com/company/edison-group-/

Twitter           www.twitter.com/Edison_Inv_Res

YouTube       www.youtube.com/edisonitv



Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1390177  05-Jul-2022 

fncls.ssp?fn=show_t_gif&application_id=1390177&application_name=news&site_id=symex